Guangzhou Hexin Instrument Hits Day Low Amid Price Pressure at CNY 109.35

Guangzhou Hexin Instrument Co., Ltd. experienced a significant decline today, with the stock dropping by 6.01% and reaching an intraday low of CNY 109.35. This performance stands in contrast to the China Shanghai Composite, which fell by only 1.26% on the same day. Over the past week, Guangzhou Hexin has seen a more pronounced decline of 16.14%, while its monthly performance shows a slight decrease of 1.39%. Despite a strong annual performance of 55.76%, the company has faced challenges in recent quarters, reporting negative results for two consecutive periods. The pre-tax profit for the latest quarter was recorded at CNY -22.89 million, reflecting a dramatic decline of 3,615.12%. Additionally, the net profit fell to CNY -18.74 million, a staggering drop of 20,339.17%. Financial metrics indicate that the company is grappling with high debt levels, as evidenced by a debt-to-equity ratio of 0.61. The stock's performance is further complicated by a weak long-term growth outlook, with net sales declining at an annual rate of 21.81% over the past five years. As a mid-cap player in the pharmaceuticals and biotechnology sector, Guangzhou Hexin's current trajectory raises concerns about its financial stability.